Tony Schapira on GBA1 Parkinson's disease
About this episode
Elena Becker-Barroso interviews Tony Schapira about GBA1-associated Parkinson's disease, discussing its genetic, clinical, and biochemical aspects.
In this episode of In Conversation With, Elena Becker-Barroso, Editor-in-Chief of The Lancet Neurology, speaks with movement disorders specialist Tony Schapira from UCL’s Queen Square Institute of Neurology about GBA1-associated Parkinson’s disease.Together, they explore the genetic, clinical, and biochemical links between GBA1 variants, lysosomal function, Gaucher disease, alpha-synuclein pathology, and Parkinson’s progression. The conversation also highlights current challenges in risk prediction, biomarkers, genetic counselling, clinical management, and emerging therapeutic approaches aimed at modifying or even preventing disease. Click here to read the full article: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(26)00090-6/fulltext
More episodes of The Lancet Neurology in conversation with
- Jan D Lünemann and Christian Münz on Epstein–Barr virus and multiple sclerosis
- Hal Dietz discusses the role of genetics in spinal CSF leaks
- Niklas Mattsson-Carlgren on the use of biomarkers in the diagnosis and stratification of Alzheimer’s disease
- Cristina Tassorelli on migraine prevention
- Inga Zerr and Simon Mead on advances in prion diseases
- Julia Greenland on azathioprine for early Parkinson’s disease
Explore listener stats, chart rankings, contacts and more on the The Lancet Neurology in conversation with podcast page.